Acne Treatments Market Report 2026

The acne treatments market size has grown strongly in recent years. It will grow from $8.81 billion in 2025 to $9.36 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to increasing prevalence of acne across age groups, wider availability of dermatological treatments, growth of clinical dermatology practices, rising acceptance of prescription acne medications, expansion of skincare-focused healthcare services.

The acne treatments market size is expected to see strong growth in the next few years. It will grow to $11.81 billion in 2030 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to increasing demand for personalized dermatology solutions, rising adoption of advanced therapeutic acne treatments, expansion of teledermatology services, growing focus on scar prevention and skin repair, increasing integration of digital skin assessment tools. Major trends in the forecast period include increasing adoption of combination acne therapies, rising demand for personalized acne treatment plans, growing use of topical prescription medications, expansion of laser and light-based acne treatments, enhanced focus on long-term skin health management.

The increasing prevalence of skin disorders is expected to drive the growth of the acne treatments market going forward. Skin disorders refer to medical conditions that affect the skin, causing changes in appearance, texture, or function. The rise in skin disorders is attributed to factors such as increased pollution, stress, and hormonal imbalances, prompting individuals to seek targeted treatments that deliver visible results, minimize side effects, and integrate easily into daily routines. Acne treatments address skin disorders by reducing inflammation, preventing breakouts, and supporting the healing of damaged skin. For instance, in July 2024, according to Cancer Research UK, a UK-based charity, the average annual number of new melanoma skin cancer cases in the UK between 2023 and 2025 is approximately 20,800, and this figure is projected to rise to 26,500 by 2038-2040. Therefore, the increasing prevalence of skin disorders is driving growth in the acne treatments market.

Key companies operating in the acne treatments market are emphasizing holistic and multi-targeted approaches, such as multi-functional exfoliating and brightening formulations, to provide consumers with solutions that treat acne while improving skin texture and reducing discoloration. A multi-functional exfoliating and brightening formulation combines ingredients that gently remove dead skin cells while diminishing dark spots and enhancing overall skin tone. For instance, in November 2024, Proactiv Company, a US-based skincare brand, launched four new dermatologist-developed products addressing acne and related concerns, including skin texture, hyperpigmentation, and body blemishes. The range comprises a salicylic acid cleanser, a brightening resurfacing mask, a blemish control body cream, and a travel-sized mini kit, offering a comprehensive acne treatment routine for clearer, healthier skin.

In May 2024, Lindus Health, a UK-based clinical trial management company, partnered with Acinonyx Bio to conduct a cosmetics clinical trial evaluating an alternative to benzoyl peroxide for inflammatory acne. Through this collaboration, Lindus Health and Acinonyx Bio aim to develop ACX, a novel topical cream designed to treat inflammatory acne, reduce reliance on benzoyl peroxide and its associated risks, decrease sebum production, unclog pores, and provide a rapidly absorbing formulation with potentially faster clinical effects. Acinonyx Bio is a US-based biotechnology company specializing in plant-based antimicrobial formulations targeting bacteria, fungi, and viruses effectively.

Major companies operating in the acne treatments market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Sanofi S.A., L'Oréal S.A., GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Shiseido Company Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Zydus Lifesciences Ltd., Glenmark Pharmaceuticals Ltd., Almirall S.A., Cipher Pharmaceuticals, Diomed Developments Limited, Galderma S.A., Bausch Health Companies Inc., F. Hoffmann‑La Roche Ltd., Novartis AG, Leo Pharma A/S, Mayne Pharma Group Ltd.

North America was the largest region in the acne treatments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acne treatments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the acne treatments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the acne treatments market by increasing costs of imported pharmaceutical ingredients, medical devices, laser treatment equipment, and advanced formulation components. Healthcare providers and pharmaceutical companies in North America and Europe are most affected due to reliance on global supply chains, while Asia-Pacific faces higher costs for exporting treatment products. These tariffs are raising treatment costs and affecting accessibility. However, they are also promoting domestic drug manufacturing, regional clinical equipment production, and innovation in cost-effective acne treatment solutions.

The acne treatments market research report is one of a series of new reports that provides acne treatments market statistics, including acne treatments industry global market size, regional shares, competitors with a acne treatments market share, detailed acne treatments market segments, market trends and opportunities, and any further data you may need to thrive in the acne treatments industry. This acne treatments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Acne treatments encompass a broad range of medical, cosmetic, and skincare solutions designed to prevent, reduce, or eliminate acne by addressing root causes such as excess oil production, clogged pores, inflammation, and bacterial growth. These treatments help control breakouts, improve skin texture, prevent scarring, and restore overall skin clarity.

The primary products of acne treatments include retinoids, antibiotics, isotretinoin, and others. Retinoids are a class of vitamin A-related compounds used in medicine and skincare to regulate cell growth and treat conditions like acne and psoriasis. Acne treatments are categorized by method into oral and topical options, allowing for systemic or localized therapy, and by acne type into inflammatory acne, cystic acne, and post-surgical or wound acne, addressing different severities and causes. These treatments include medications, therapeutic interventions, and laser treatments, and are utilized by hospitals, clinics, pharmacies, drug stores, e-commerce platforms, and ambulatory surgical centers.

The acne treatments market consists of revenues earned by entities by providing services such as chemical peels, photodynamic therapy (PDT), microneedling, medical facials, corticosteroid injections, and extraction services. The market value includes the value of related goods sold by the service provider or included within the service offering. The acne treatments market also includes sales of differin gel, Neutrogena Oil-Free Acne Wash, Proactiv 3-Step System, benzoyl peroxide, and Aviclear laser. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.